Suppr超能文献

结直肠肿瘤中 S100A4、S100A6、S100A8、S100A9、S100A11 和 S100P 蛋白的组织 mRNA:一项初步研究。

Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.

机构信息

2nd Department of Internal Medicine-Gastroenterology, Charles University, Faculty of Medicine in Hradec Kralove, University Hospital, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.

Department of Medical Biochemistry, Charles University, Faculty of Medicine in Hradec Kralove, Simkova 870, 500 01 Hradec Kralove, Czech Republic.

出版信息

Molecules. 2021 Jan 14;26(2):402. doi: 10.3390/molecules26020402.

Abstract

S100 proteins are involved in the pathogenesis of sporadic colorectal carcinoma through different mechanisms. The aim of our study was to assess tissue mRNA encoding S100 proteins in patients with non-advanced and advanced colorectal adenoma. Mucosal biopsies were taken from the caecum, transverse colon and rectum during diagnostic and/or therapeutic colonoscopy. Another biopsy was obtained from adenomatous tissue in the advanced adenoma group. The tissue mRNA for each S100 protein (S100A4, S100A6, S100A8, S100A9, S100A11 and S100P) was investigated. Eighteen biopsies were obtained from the healthy mucosa in controls and the non-advanced adenoma group (six individuals in each group) and thirty biopsies in the advanced adenoma group (ten patients). Nine biopsies were obtained from advanced adenoma tissue (9/10 patients). Significant differences in mRNA investigated in the healthy mucosa were identified between (1) controls and the advanced adenoma group for S100A6 ( = 0.012), (2) controls and the non-advanced adenoma group for S100A8 ( = 0.033) and (3) controls and the advanced adenoma group for S100A11 ( = 0.005). In the advanced adenoma group, differences between the healthy mucosa and adenomatous tissue were found in S100A6 ( = 0.002), S100A8 ( = 0.002), S100A9 ( = 0.021) and S100A11 ( = 0.029). Abnormal mRNA expression for different S100 proteins was identified in the pathological adenomatous tissue as well as in the morphologically normal large intestinal mucosa.

摘要

S100 蛋白通过不同的机制参与散发性结直肠癌的发病机制。我们的研究目的是评估非晚期和晚期结直肠腺瘤患者组织中编码 S100 蛋白的 mRNA。在诊断和/或治疗性结肠镜检查期间,从盲肠、横结肠和直肠采集黏膜活检。在高级别腺瘤组中,从腺瘤组织中获得另一个活检。研究了每个 S100 蛋白(S100A4、S100A6、S100A8、S100A9、S100A11 和 S100P)的组织 mRNA。对照组和非晚期腺瘤组(每组 6 人)的健康黏膜中获得了 18 个活检,高级别腺瘤组中获得了 30 个活检(10 例患者)。从高级别腺瘤组织中获得了 9 个活检(9/10 例患者)。在健康黏膜中研究的 mRNA 存在显著差异,包括:(1)S100A6 在对照组和高级别腺瘤组之间(=0.012),(2)S100A8 在对照组和非高级别腺瘤组之间(=0.033),以及(3)S100A11 在对照组和高级别腺瘤组之间(=0.005)。在高级别腺瘤组中,在健康黏膜和腺瘤组织之间发现 S100A6(=0.002)、S100A8(=0.002)、S100A9(=0.021)和 S100A11(=0.029)存在差异。不同 S100 蛋白的异常 mRNA 表达在病理性腺瘤组织以及形态正常的大肠黏膜中均有发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5289/7828666/1ba38ed38929/molecules-26-00402-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验